Kodiak Sciences Inc. (KOD) intrinsic value & 10-year financials
Kodiak Sciences Inc. (KOD) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $85.75
- Market cap
- $4.6B
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 6913.9%
- Free cash flow (FY2025)
- -$136.5M
KOD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$230.0M | -$4.32 | -$136.5M | — | -1281.9% |
| FY2024 | — | -$176.2M | -$3.35 | -$117.7M | — | -397.3% |
| FY2023 | — | -$260.5M | -$4.97 | -$195.5M | — | -147.6% |
| FY2022 | — | -$333.8M | -$6.39 | -$243.5M | — | -206.0% |
| FY2021 | — | -$267.0M | -$5.16 | -$199.3M | — | 71787.9% |
| FY2020 | — | -$133.1M | -$2.91 | -$87.2M | — | -215.1% |
| FY2019 | — | -$47.4M | — | -$39.6M | — | -35.1% |
| FY2018 | — | -$41.4M | — | -$29.1M | — | -458.1% |
| FY2017 | — | -$27.9M | — | -$17.9M | — | 50.9% |
| FY2016 | — | -$17.1M | — | -$16.8M | — | 41.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Kodiak Sciences Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Kodiak Sciences Inc. has earned high returns on invested capital, averaging 60.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Kodiak Sciences Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Kodiak Sciences Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.